AMARIN CORP PLC\UK Selling, General and Administrative Expense
AMARIN CORP PLC\UK (AMRN) reported Selling, General and Administrative Expense of $22.19 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-29
- AMARIN CORP PLC\UK selling, general and administrative expense for the quarter ending 2026-06-30 was $22.19M, a 42.63% decline year-over-year.
- AMARIN CORP PLC\UK selling, general and administrative expense for the quarter ending 2026-03-31 was $21.11M, a 42.27% decline year-over-year.
- AMARIN CORP PLC\UK selling, general and administrative expense for the quarter ending 2025-12-31 was $20.06M, a 45.74% decline year-over-year.
- AMARIN CORP PLC\UK selling, general and administrative expense for the quarter ending 2025-09-30 was $19.70M, a 46.63% decline year-over-year.
- AMARIN CORP PLC\UK selling, general and administrative expense for fiscal 2025 was $115.00M, a 24.49% decline from fiscal 2024.
- AMARIN CORP PLC\UK selling, general and administrative expense for fiscal 2024 was $152.31M, a 23.82% decline from fiscal 2023.
- AMARIN CORP PLC\UK selling, general and administrative expense for fiscal 2023 was $199.94M, a 34.32% decline from fiscal 2022.
- AMARIN CORP PLC\UK selling, general and administrative expense for fiscal 2022 was $304.42M, a 25.45% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $22.19M 10-Q · filed 2026-07-29 | $43.30M 10-Q · filed 2026-07-29 | $63.36M derived: sum of 3 quarters · filed 2026-07-29 | $83.06M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $21.11M 10-Q · filed 2026-04-29 | $41.17M derived: sum of 2 quarters · filed 2026-04-29 | $60.87M derived: sum of 3 quarters · filed 2026-04-29 | $99.54M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $20.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $39.76M derived: sum of 2 quarters · filed 2026-03-02 | $78.43M derived: sum of 3 quarters · filed 2026-07-29 | $115.00M 10-K · filed 2026-03-02 |
| 2025-09-30 | $19.70M 10-Q · filed 2025-10-29 | $58.37M derived: sum of 2 quarters · filed 2026-07-29 | $94.94M 10-Q · filed 2025-10-29 | $131.91M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $38.67M 10-Q · filed 2026-07-29 | $75.25M 10-Q · filed 2026-07-29 | $112.22M derived: sum of 3 quarters · filed 2026-07-29 | $149.12M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $36.57M 10-Q · filed 2026-04-29 | $73.54M derived: sum of 2 quarters · filed 2026-04-29 | $110.45M derived: sum of 3 quarters · filed 2026-04-29 | $148.99M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $36.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $73.87M derived: sum of 2 quarters · filed 2026-03-02 | $112.42M derived: sum of 3 quarters · filed 2026-03-02 | $152.31M 10-K · filed 2026-03-02 |
| 2024-09-30 | $36.90M 10-Q · filed 2025-10-29 | $75.45M derived: sum of 2 quarters · filed 2025-10-29 | $115.34M 10-Q · filed 2025-10-29 | $159.28M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $38.55M 10-Q · filed 2025-07-30 | $78.44M 10-Q · filed 2025-07-30 | $122.38M derived: sum of 3 quarters · filed 2026-03-02 | $167.83M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $39.89M 10-Q · filed 2025-05-07 | $83.83M derived: sum of 2 quarters · filed 2026-03-02 | $129.29M derived: sum of 3 quarters · filed 2026-03-02 | $180.24M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $43.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $89.40M derived: sum of 2 quarters · filed 2026-03-02 | $140.35M derived: sum of 3 quarters · filed 2026-03-02 | $199.94M 10-K · filed 2026-03-02 |
| 2023-09-30 | $45.46M 10-Q · filed 2024-10-30 | $96.41M derived: sum of 2 quarters · filed 2024-10-30 | $156.00M 10-Q · filed 2024-10-30 | $224.13M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-06-30 | $50.95M 10-Q · filed 2024-07-31 | $110.54M 10-Q · filed 2024-07-31 | $178.67M derived: sum of 3 quarters · filed 2025-03-12 | $237.42M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-03-31 | $59.59M 10-Q · filed 2024-05-01 | $127.72M derived: sum of 2 quarters · filed 2025-03-12 | $186.46M derived: sum of 3 quarters · filed 2025-03-12 | $273.36M derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | $68.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $126.88M derived: sum of 2 quarters · filed 2025-03-12 | $213.77M derived: sum of 3 quarters · filed 2025-03-12 | $304.42M 10-K · filed 2025-03-12 |
| 2022-09-30 | $58.74M 10-Q · filed 2023-11-01 | $145.64M derived: sum of 2 quarters · filed 2023-11-01 | $236.28M 10-Q · filed 2023-11-01 | $328.65M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $86.89M 10-Q · filed 2023-08-02 | $177.54M 10-Q · filed 2023-08-02 | $269.91M derived: sum of 3 quarters · filed 2024-02-29 | $372.87M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $90.65M 10-Q · filed 2023-05-03 | $183.01M derived: sum of 2 quarters · filed 2024-02-29 | $285.98M derived: sum of 3 quarters · filed 2024-02-29 | $393.18M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $92.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $195.33M derived: sum of 2 quarters · filed 2024-02-29 | $302.54M derived: sum of 3 quarters · filed 2024-02-29 | $408.33M 10-K · filed 2024-02-29 |
| 2021-09-30 | $102.97M 10-Q · filed 2022-10-27 | $210.17M derived: sum of 2 quarters · filed 2022-10-27 | $315.97M 10-Q · filed 2022-10-27 | $432.78M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $107.20M 10-Q · filed 2022-08-03 | $213.00M 10-Q · filed 2022-08-03 | $329.82M derived: sum of 3 quarters · filed 2023-03-01 | $449.98M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $105.80M 10-Q · filed 2022-05-04 | $222.61M derived: sum of 2 quarters · filed 2023-03-01 | $342.78M derived: sum of 3 quarters · filed 2023-03-01 | $435.17M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $116.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $236.98M derived: sum of 2 quarters · filed 2023-03-01 | $329.38M derived: sum of 3 quarters · filed 2023-03-01 | $463.31M 10-K · filed 2023-03-01 |
| 2020-09-30 | $120.16M 10-Q · filed 2021-11-03 | $212.56M derived: sum of 2 quarters · filed 2021-11-03 | $346.50M 10-Q · filed 2021-11-03 | $442.52M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $92.39M 10-Q · filed 2021-08-05 | $226.33M 10-Q · filed 2021-08-05 | $322.36M derived: sum of 3 quarters · filed 2022-03-01 | $404.92M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $133.94M 10-Q · filed 2021-04-29 | $229.96M derived: sum of 2 quarters · filed 2022-03-01 | $312.52M derived: sum of 3 quarters · filed 2022-03-01 | $385.93M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $96.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $178.58M derived: sum of 2 quarters · filed 2022-03-01 | $251.99M derived: sum of 3 quarters · filed 2022-03-01 | $323.62M 10-K · filed 2022-03-01 |
| 2019-09-30 | $82.56M 10-Q · filed 2020-11-05 | $155.97M derived: sum of 2 quarters · filed 2020-11-05 | $227.60M 10-Q · filed 2020-11-05 | $307.28M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $73.41M 10-Q · filed 2020-08-04 | $145.04M 10-Q · filed 2020-08-04 | $224.72M derived: sum of 3 quarters · filed 2021-02-25 | $274.69M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $71.63M 10-Q · filed 2020-04-30 | $151.32M derived: sum of 2 quarters · filed 2021-02-25 | $201.28M derived: sum of 3 quarters · filed 2021-02-25 | $255.22M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $79.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $129.65M derived: sum of 2 quarters · filed 2021-02-25 | $183.59M derived: sum of 3 quarters · filed 2021-02-25 | $227.00M 10-K · filed 2021-02-25 |
| 2018-09-30 | $49.96M 10-Q · filed 2019-11-05 | $103.90M derived: sum of 2 quarters · filed 2019-11-05 | $147.31M 10-Q · filed 2019-11-05 | $182.95M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $53.94M 10-Q · filed 2019-07-31 | $97.35M 10-Q · filed 2019-07-31 | $132.99M derived: sum of 3 quarters · filed 2020-02-25 | $166.18M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $43.41M 10-Q · filed 2019-05-01 | $79.05M derived: sum of 2 quarters · filed 2020-02-25 | $112.24M derived: sum of 3 quarters · filed 2020-02-25 | $143.78M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $35.64M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $68.83M derived: sum of 2 quarters · filed 2020-02-25 | $100.38M derived: sum of 3 quarters · filed 2020-02-25 | $134.55M 10-K · filed 2020-02-25 |
| 2017-09-30 | $33.19M 10-Q · filed 2018-11-01 | $64.74M derived: sum of 2 quarters · filed 2018-11-01 | $98.91M 10-Q · filed 2018-11-01 | $130.13M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $31.55M 10-Q · filed 2018-08-01 | $65.72M 10-Q · filed 2018-08-01 | $96.94M derived: sum of 3 quarters · filed 2019-02-27 | $123.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $34.17M 10-Q · filed 2018-05-02 | $65.40M derived: sum of 2 quarters · filed 2019-02-27 | $91.46M derived: sum of 3 quarters · filed 2019-02-27 | $117.52M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $31.23M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $57.29M derived: sum of 2 quarters · filed 2019-02-27 | $83.35M derived: sum of 3 quarters · filed 2019-02-27 | $111.37M 10-K · filed 2019-02-27 |
| 2016-09-30 | $26.06M 10-Q · filed 2017-11-01 | $52.13M derived: sum of 2 quarters · filed 2017-11-01 | $80.15M 10-Q · filed 2017-11-01 | $103.67M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $26.07M 10-Q · filed 2017-08-02 | $54.09M 10-Q · filed 2017-08-02 | $77.61M derived: sum of 3 quarters · filed 2018-02-27 | $104.33M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $28.02M 10-Q · filed 2017-05-03 | $51.54M derived: sum of 2 quarters · filed 2018-02-27 | $78.27M derived: sum of 3 quarters · filed 2018-02-27 | $104.32M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $23.52M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $50.25M derived: sum of 2 quarters · filed 2018-02-27 | $76.30M derived: sum of 3 quarters · filed 2018-02-27 | $101.04M 10-K · filed 2018-02-27 |
| 2015-09-30 | $26.73M 10-Q · filed 2016-11-03 | $52.78M derived: sum of 2 quarters · filed 2016-11-03 | $77.52M 10-Q · filed 2016-11-03 | $95.92M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $26.05M 10-Q · filed 2016-08-04 | $50.80M 10-Q · filed 2016-08-04 | $69.19M derived: sum of 3 quarters · filed 2017-03-01 | $88.46M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $24.74M 10-Q · filed 2016-05-05 | $43.14M derived: sum of 2 quarters · filed 2017-03-01 | $62.41M derived: sum of 3 quarters · filed 2017-03-01 | $83.50M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $18.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $37.67M derived: sum of 2 quarters · filed 2017-03-01 | $58.76M derived: sum of 3 quarters · filed 2017-03-01 | $79.35M 10-K · filed 2017-03-01 |
| 2014-09-30 | $19.27M 10-Q · filed 2015-11-04 | $40.36M derived: sum of 2 quarters · filed 2015-11-04 | $60.95M 10-Q · filed 2015-11-04 | $83.24M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $21.09M 10-Q · filed 2015-08-06 | $41.68M 10-Q · filed 2015-08-06 | $63.97M derived: sum of 3 quarters · filed 2016-02-25 | $92.25M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $20.59M 10-Q · filed 2015-05-08 | $42.88M derived: sum of 2 quarters · filed 2016-02-25 | $71.15M derived: sum of 3 quarters · filed 2016-02-25 | $105.11M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $22.29M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $50.57M derived: sum of 2 quarters · filed 2016-02-25 | $84.53M derived: sum of 3 quarters · filed 2016-02-25 | $123.80M 10-K · filed 2016-02-25 |
| 2013-09-30 | $28.27M 10-Q · filed 2014-11-06 | $62.23M derived: sum of 2 quarters · filed 2014-11-06 | $101.50M 10-Q · filed 2014-11-06 | $118.24M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | $33.96M 10-Q · filed 2014-08-07 | $73.23M 10-Q · filed 2014-08-07 | $89.96M derived: sum of 3 quarters · filed 2015-03-03 | $103.36M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-31 | $39.27M 10-Q · filed 2014-05-09 | $56.00M derived: sum of 2 quarters · filed 2015-03-03 | $69.40M derived: sum of 3 quarters · filed 2015-03-03 | $83.03M derived: sum of 4 quarters · filed 2015-03-03 |
| 2012-12-31 | $16.73M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $30.13M derived: sum of 2 quarters · filed 2015-03-03 | $43.77M derived: sum of 3 quarters · filed 2015-03-03 | $57.79M 10-K · filed 2015-03-03 |
| 2012-09-30 | $13.40M 10-Q · filed 2013-11-07 | $27.03M derived: sum of 2 quarters · filed 2013-11-07 | $41.06M 10-Q · filed 2013-11-07 | $47.43M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $13.63M 10-Q · filed 2013-08-08 | $27.66M 10-Q · filed 2013-08-08 | $34.04M derived: sum of 3 quarters · filed 2014-02-27 | $37.47M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $14.03M 10-Q · filed 2013-05-09 | $20.40M derived: sum of 2 quarters · filed 2014-02-27 | $23.83M derived: sum of 3 quarters · filed 2014-02-27 | $33.86M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $6.37M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $9.81M derived: sum of 2 quarters · filed 2014-02-27 | $19.83M derived: sum of 3 quarters · filed 2014-02-27 | $22.56M 10-K · filed 2014-02-27 |
| 2011-09-30 | $3.43M 10-Q · filed 2012-11-08 | $13.46M derived: sum of 2 quarters · filed 2012-11-08 | $16.18M 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $10.03M 10-Q · filed 2012-08-08 | $12.75M 10-Q · filed 2012-08-08 | ||
| 2011-03-31 | $2.73M 10-Q · filed 2012-05-08 | |||
| 2010-09-30 | $2.13M 10-Q · filed 2011-11-08 | $4.95M derived: sum of 2 quarters · filed 2011-11-08 | $7.21M 10-Q · filed 2011-11-08 | |
| 2010-06-30 | $2.82M 10-Q · filed 2011-08-09 | $5.07M 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |